Bausch Health Companies (BHC) Change in Intangibles (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Change in Intangibles came in at $38.0 million in Q1 2026, up 322.22% year-on-year from $9.0 million in Q1 2025, and up 3700.0% quarter-over-quarter from $1.0 million in Q2 2025.
Bausch Health Companies (BHC) Change in Intangibles (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Change in Intangibles across 18 years of filings, most recently posting $38.0 million for Q1 2026.
- Change in Intangibles for Q1 2026 came in at $38.0 million, up 322.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.0 million (up 254.55% YoY), and the FY2025 annual result was $10.0 million, up 233.33% from the prior year.
- Change in Intangibles came in at $38.0 million for Q1 2026 at Bausch Health Companies, up from $1.0 million in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $46.0 million in Q4 2023 to a low of $1.0 million in Q1 2024.
- The 5-year median for Change in Intangibles is $4.0 million (2022), against an average of $11.3 million.
- Across the five-year window, Change in Intangibles plunged 97.83% in 2024 and surged 800.0% in 2025, its largest moves.
- Bausch Health Companies' Change in Intangibles stood at $30.0 million in 2022, then soared by 53.33% to $46.0 million in 2023, then slumped by 97.83% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025, then surged by 3700.0% to $38.0 million in 2026.
- The last three Change in Intangibles figures came in at $38.0 million (Q1 2026), $1.0 million (Q2 2025), and $9.0 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Bausch Health Companies | 1.93 Bn | 1.59 Bn | 2.48 Bn | 38.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.00 Mn |
| Mar 31, 2026 | 38.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 9.00 Mn |
| Mar 31, 2025 | 9.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | 46.00 Mn |
| Dec 31, 2023 | 46.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 3.00 Mn |
| Jun 30, 2023 | 3.00 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Mar 31, 2023 | 4.00 Mn |